CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222343568
- Phone
- 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 8-K Event Shareholder vote results
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4/A Insider Changes in Ownership
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 4 Insider Changes in Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- CT ORDER Other Confidential Order
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-Q/A Report 10-Q/A
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K/A Report 10-K/A
- UPLOAD Other SEC-generated Letter
Page 26 of 80 · 1,585 filings